Clinical Trial Update: Phase 3 Clinical Study of AK112 for NSCLC Patients [Phase 3]

View source ↗

Summary

Phase 3 trial update for AK112 in non-small cell lung cancer; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AK112

Snippet

Sponsor: Akeso | Conditions: Non-Squamous Non-small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING